Federal Judge Decides Trovan Class Action Would Be Better Litigated in Nigeria




NEW YORK-A putative class action filed by the parents and guardians of children who were allegedly injured as the result Pfizer's experimental administration of Trovan is better suited for litigation in Nigeria, a federal judge ruled. Abdullahi, et al., v. Pfizer Inc., No. 01-CV-8118 (S.D. N.Y.).

U.S. District Judge William H. Pauley, III's Sept. 17 order granted Pfizer's motion to dismiss on grounds of forum non conveniens provided that the manufacturer consents to process the plaintiffs' suit in Nigeria, waives any statute of limitations defense, covers the cost of discovery at its own expense and agrees to litigate the case …






UPCOMING CONFERENCES




HarrisMartin's Webinar Series: Midwest Asbestos Litigation

December 02, 2020 - Haddonfield, NJ
HarrisMartin Webinar Series

MORE DETAILS